China To Clamp Down On Medical Diagnostics, Device Implants
This article was originally published in PharmAsia News
Executive Summary
China has issued a clampdown on use of artificial heart implants and other therapeutic technologies and diagnostics considered to have a high risk. The Ministry of Health said it would tighten its regulations to the point hospitals will have to get approval before conducting heart implants or transplants. The regulatory changes are to take place May 1. The ministry cited abuses of medical technologies, some by persons not qualified to use them. By November, hospitals will be required to verify the qualifications of persons operating those technologies. (Click here for more